Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction

NCT04202445 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT04202445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04202445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients Satisfaction
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
February 29, 2016
Enrollment
1,218 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis